BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,459,000 | +32.9% | 173,910 | +96.1% | 0.02% | +57.1% |
| Q1 2021 | $8,624,000 | +41.3% | 88,700 | -15.0% | 0.01% | -12.5% |
| Q1 2020 | $6,105,000 | +183.7% | 104,400 | +256.5% | 0.02% | +220.0% |
| Q3 2019 | $2,152,000 | -44.2% | 29,284 | -28.4% | 0.01% | -44.4% |
| Q2 2019 | $3,858,000 | +39.3% | 40,900 | -58.6% | 0.01% | +28.6% |
| Q4 2016 | $2,769,000 | -5.5% | 98,700 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $2,931,000 | -70.4% | 98,700 | -79.8% | 0.01% | -70.8% |
| Q2 2016 | $9,886,000 | +18.3% | 488,222 | +5.4% | 0.02% | +20.0% |
| Q1 2016 | $8,357,000 | -7.7% | 462,997 | +34.7% | 0.02% | 0.0% |
| Q4 2015 | $9,055,000 | +327.3% | 343,777 | +246.2% | 0.02% | +300.0% |
| Q3 2015 | $2,119,000 | -19.4% | 99,300 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $2,630,000 | – | 99,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |